Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes.

Elaine Ku,Charles E McCulloch,Timothy P Copeland,Lesley A Inker,Hocine Tighiouart,Mark J Sarnak

American journal of kidney diseases : the official journal of the National Kidney Foundation（2023）

引用 0|浏览15

暂无评分

摘要

Declines in eGFR >15% in both the usual and intensive BP treatment arms were associated with a higher risk of kidney outcomes in comparison with a ≤15% decline in the usual BP arm and may be a harbinger of adverse outcomes.

查看译文

关键词

blood pressure target trials,estimated gfr,adverse outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要